サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790398

米国の電気生理学マッピングアブレーション装置市場規模、シェア、動向分析レポート：手技タイプ別、製品範囲別、セグメント別予測、2025年～2033年

U.S. Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type (EP Ablation Procedures, Stand-Alone EP Diagnostic Procedures), By Product Coverage, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
米国の電気生理学マッピングアブレーション装置市場規模、シェア、動向分析レポート：手技タイプ別、製品範囲別、セグメント別予測、2025年～2033年
出版日: 2025年07月31日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の電気生理学マッピングアブレーション装置市場サマリー

米国の電気生理学マッピングアブレーション装置市場規模は、2024年に104億7,000万米ドルと推計され、2033年には231億1,000万米ドルに達すると予測され、2025年から2033年までのCAGRは8.05%で成長すると予測されます。米国における電気生理学（EP）マッピングアブレーション機器の普及は、心房細動やその他の複雑な不整脈、特に高齢化やリスクの高い集団における負担の増大が原動力となっています。

米国における肥満率の上昇、高血圧、糖尿病の流行は、手術件数の増加に寄与し、高度な診断・治療EP技術に対する需要を加速しています。CDCによると、米国では2030年までに約1,210万人が心房細動に罹患するとされています。米国における不整脈、特に心房細動の負担の増大は、電気生理学（EP）マッピングおよびアブレーション装置の採用拡大を促進しています。

病院や専門センターが心臓病プログラムを拡大するにつれて、より迅速で正確な診断と的を絞った治療を可能にするツールに対する需要が高まっています。202年3月、Clinical Cardiology誌は、米国における25年間の不整脈関連死亡の分析結果を発表し、1999年から2023年までの35歳以上の成人における死亡数は505万人であったと報告しました。死亡率は1999年から2009年まで低下し、その後順調に上昇し、2021年のCOVID-19パンデミック時にピークに達した後、わずかに低下しました。

技術的進歩は依然として市場成長の主要な促進要因です。3Dマッピングシステム、パルスフィールドアブレーションプラットフォーム、AIガイド付きナビゲーションなどの技術革新により、精度が向上し、手技リスクが低減しています。これらの技術は、ワークフローを合理化し、治療成績を向上させ、競争が激化する電気生理学的状況で優位に立とうとする米国の医療提供者の間で支持を集めています。2025年6月、Phillips Medisizeは、高電圧、多ピン数の電気生理学（EP）マッピングおよびアブレーション機器に合わせた医療用コネクタの初のブランドラインであるTheraVoltを発売しました。パルスフィールド焼灼療法をサポートするよう設計されたTheraVoltは、高密度統合とプラットフォームの柔軟性を備えたカスタマイズ可能な滅菌対応ソリューションを提供します。

米国全土で高まる認識とスクリーニングの取り組みが、EP技術の使用を加速しています。地域医療プログラム、医療システム主導のアウトリーチ、積極的なリズムモニタリングは、不整脈の早期発見に役立っています。合併症が生じる前に診断される患者が増えるにつれて、診断・治療EP手技とそれをサポートする機器に対する需要は増加の一途をたどっています。2025年7月、PCNAが発表した白書は、メリーランド州ボルチモアにおける心房細動（AFib）と高血圧を対象とした地域ベースのスクリーニングイニシアチブの成果を評価したものです。この報告書では、心房細動はエピソード性の症状のため、依然として診断が不十分であり、2030年までに患者数が1,210万人に増加すると予測されていることから、早期かつ低侵襲な診断ソリューションの必要性が高まっていることが強調されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の電気生理学マッピングアブレーション装置市場の変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国の電気生理学マッピングアブレーション装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の電気生理学マッピングアブレーション装置市場：手技タイプの推定・動向分析

  • 米国の電気生理学マッピングアブレーション装置：手技タイプダッシュボード
  • 米国の電気生理学マッピングアブレーション装置：手技タイプ変動分析
  • 米国の電気生理学マッピングアブレーション装置市場規模、予測、動向分析（手技タイプ別、2021年～2033年）
  • EPアブレーション手順
    • 適応症別
    • 心房細動
    • 右心房粗動
    • 左心房粗動
    • 房室結節リエントリー性頻拍（AVNRT）
    • 右心房頻拍（AT）
    • 左房頻拍（AT）
    • 右ウォルフ・パーキンソン・ホワイト症候群（WPW）
    • 左Wolff-Parkinson-White症候群（WPW）
    • 右室頻拍（VT）
    • 左室頻拍（VT）
    • 製品タイプ
  • スタンドアロンEP診断手順

第5章 米国の電気生理学マッピングアブレーション装置市場：製品範囲の推定・動向分析

  • 米国の電気生理学マッピングアブレーション装置市場：製品範囲ダッシュボード
  • 米国の電気生理学マッピングアブレーション装置市場：製品範囲変動分析
  • 米国の電気生理学マッピングアブレーション装置市場規模、予測、動向分析（製品範囲別、2021年～2033年）
  • マッピングとラボシステム
    • X線システム
    • マッピングシステム
    • EPレコーディングシステム
    • ICEシステム
    • RFアブレーションジェネレータ
    • パルスフィールドアブレーションジェネレータ
    • クライオアブレーションジェネレータ
  • 診断用カテーテル
    • 従来型
    • 先進型
    • 超音波
  • アブレーションカテーテル
    • 局所アブレーションカテーテル
    • バルーンアブレーションカテーテル
  • アクセサリデバイス
    • ロングイントロデューサーシース
    • 経中隔針
    • ナビゲーションアクセサリ

第6章 競合情勢

  • 主要メーカーによる最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • Key customers
    • Key company market share analysis, 2024
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Abbott
    • Johnson &Johnson（Biosense Webster）
    • GE HealthCare
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik SE &Co KG
    • MicroPort Scientific Corporation
    • CardioFocus, Inc.
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. electrophysiology mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Million)
  • Table 4. U.S. electrophysiology mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. electrophysiology mapping and ablation devices market: outlook
  • Fig. 9 U.S. electrophysiology (EP) mapping and ablation devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 U.S. electrophysiology mapping and ablation devices market driver impact
  • Fig. 13 U.S. electrophysiology mapping and ablation devices market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 U.S. electrophysiology mapping and ablation devices market: Procedure type movement analysis
  • Fig. 17 U.S. electrophysiology mapping and ablation devices market: Procedure type outlook and key takeaways
  • Fig. 18 EP ablation procedures market, 2021 - 2033 (USD Million)
  • Fig. 19 Atrial fibrillation market, 2021 - 2033 (USD Million)
  • Fig. 20 Paroxysmal AF market, 2021 - 2033 (USD Million)
  • Fig. 21 Persistent AF market, 2021 - 2033 (USD Million)
  • Fig. 22 Long standing persistent/permanent market, 2021 - 2033 (USD Million)
  • Fig. 23 Right atrial flutter market, 2021 - 2033 (USD Million)
  • Fig. 24 Left atrial flutter market, 2021 - 2033 (USD Million)
  • Fig. 25 Atrioventricular nodal reentry tachycardia (AVNRT) market, 2021 - 2033 (USD Million)
  • Fig. 26 Left atrial tachycardia (AT) market, 2021 - 2033 (USD Million)
  • Fig. 27 Right atrial tachycardia (AT) market, 2021 - 2033 (USD Million)
  • Fig. 28 Right wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Million)
  • Fig. 29 Left wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Million)
  • Fig. 30 Right ventricular tachycardia (VT) market, 2021 - 2033 (USD Million)
  • Fig. 31 Left ventricular tachycardia (VT) market, 2021 - 2033 (USD Million)
  • Fig. 32 Stand-alone EP diagnostic procedures market, 2021 - 2033 (USD Million)
  • Fig. 33 By product type market, 2021 - 2033 (USD Million)
  • Fig. 34 Focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 35 Radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 36 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 37 Irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 38 Contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 39 Standard market, 2021 - 2033 (USD Million)
  • Fig. 40 Alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 41 Pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 42 Balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. electrophysiology mapping and ablation devices market: Product coverage movement analysis
  • Fig. 44 U.S. electrophysiology mapping and ablation devices market: Product coverage outlook and key takeaways
  • Fig. 45 Mapping & lab systems market, 2021 - 2033 (USD Million)
  • Fig. 46 X-ray systems market, 2021 - 2033 (USD Million)
  • Fig. 47 Mapping systems market, 2021 - 2033 (USD Million)
  • Fig. 48 EP recording systems market, 2021 - 2033 (USD Million)
  • Fig. 49 ICE systems market, 2021 - 2033 (USD Million)
  • Fig. 50 RF ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 51 Pulsed field ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 52 Cryoablation generators market, 2021 - 2033 (USD Million)
  • Fig. 53 Diagnostic catheters market, 2021 - 2033 (USD Million)
  • Fig. 54 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 55 Fixed market, 2021 - 2033 (USD Million)
  • Fig. 56 Steerable market, 2021 - 2033 (USD Million)
  • Fig. 57 Advanced market, 2021 - 2033 (USD Million)
  • Fig. 58 Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 59 Ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 60 Focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 61 Radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 62 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 63 Irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 64 Contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 65 Standard market, 2021 - 2033 (USD Million)
  • Fig. 66 Alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 67 Pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 68 Balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 69 Accessory devices market, 2021 - 2033 (USD Million)
  • Fig. 70 Long introducer sheaths market, 2021 - 2033 (USD Million)
  • Fig. 71 Fixed market, 2021 - 2033 (USD Million)
  • Fig. 72 Steerable market, 2021 - 2033 (USD Million)
  • Fig. 73 Transseptal needles market, 2021 - 2033 (USD Million)
  • Fig. 74 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 75 RF market, 2021 - 2033 (USD Million)
  • Fig. 76 Navigational accessories market, 2021 - 2033 (USD Million)
  • Fig. 77 Market participant categorization
  • Fig. 78 Strategy mapping
  • Fig. 79 Key company categorization
  • Fig. 80 Heat map analysis 2024
目次
Product Code: GVR-4-68040-694-8

U.S. Electrophysiology Mapping and Ablation Devices Market Summary

The U.S. electrophysiology mapping and ablation devices market size was estimated at USD 10.47 billion in 2024 and is projected to reach USD 23.11 billion by 2033, growing at a CAGR of 8.05% from 2025 to 2033. Widespread use of electrophysiology (EP) mapping and ablation devices in the U.S. is being driven by the escalating burden of atrial fibrillation and other complex arrhythmias, particularly among aging and at-risk populations.

As clinical guidelines increasingly favor early interventional treatment, hospitals and ambulatory centers are expanding their EP capabilities.Rising obesity rates, hypertension, and diabetes prevalence in the U.S. are contributing to increased procedure volumes and accelerating the demand for advanced diagnostic and therapeutic EP technologies. According to the CDC, approximately 12.1 million people in the U.S. will be suffering from atrial fibrillation by 2030. The growing burden of arrhythmias in the U.S., particularly atrial fibrillation, is driving increased adoption of electrophysiology (EP) mapping and ablation devices.

As hospitals and specialty centers expand their cardiac programs, there is a rising demand for tools that enable faster, more accurate diagnosis and targeted treatment. In March 202, Clinical Cardiology published a 25-year analysis of arrhythmia-related deaths in the U.S., reporting 5.05 million deaths among adults aged 35+ from 1999-2023. Mortality fell from 1999 to 2009, then rose steadily, peaking in 2021 during the COVID-19 pandemic before declining slightly.

Technological advancement remains a key driver of market growth. Innovations in 3D mapping systems, pulsed field ablation platforms, and AI-guided navigation are improving precision and reducing procedural risk. These technologies are gaining traction among U.S. providers seeking to streamline workflows, enhance outcomes, and stay ahead in an increasingly competitive electrophysiology landscape. In June 2025, Phillips Medisize launched TheraVolt, its first branded line of medical connectors tailored for high-voltage, high pin-count electrophysiology (EP) mapping and ablation devices. Designed to support pulsed field ablation therapies, TheraVolt offers customizable, sterilization-compatible solutions with high-density integration and platform flexibility.

Growing awareness and screening initiatives across the U.S. are accelerating the use of EP technologies. Community health programs, health system-led outreach, and proactive rhythm monitoring are helping identify arrhythmias earlier. As more patients are diagnosed before complications arise, demand for diagnostic and therapeutic EP procedures and the devices that support them continues to rise. In July 2025, a white paper published by PCNA evaluated the outcomes of a community-based screening initiative targeting atrial fibrillation (AFib) and hypertension in Baltimore, Maryland. The report noted that AFib remains underdiagnosed due to its episodic symptoms, underscoring the growing need for early, minimally invasive diagnostic solutions as cases are projected to rise to 12.1 million by 2030.

U.S. Electrophysiology Mapping And Ablation Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. electrophysiology mapping and ablation devices market report based on procedure type and product coverage:

  • Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
  • EP Ablation Procedures
    • By Indication
    • Atrial Fibrillation
    • Paroxysmal AF
    • Persistent AF
    • Long standing persistent/permanent
    • Right Atrial Flutter
    • Left Atrial Flutter
    • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
    • Right Atrial Tachycardia (AT)
    • Left Atrial Tachycardia (AT)
    • Right Wolff-Parkinson-White (WPW)
    • Left Wolff-Parkinson-White (WPW)
    • Right Ventricular Tachycardia (VT)
    • Left Ventricular Tachycardia (VT)
  • Stand-Alone EP Diagnostic Procedures
    • By Product Type
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Product Coverage Outlook (Revenue, USD Million, 2021 - 2033)
  • Mapping & Lab Systems
    • X-Ray Systems
    • Mapping Systems
    • EP Recording Systems
    • ICE Systems
    • RF Ablation Generators
    • Pulsed Field Ablation Generators
    • Cryoablation Generators
  • Diagnostic Catheters
    • Conventional
    • Fixed
    • Steerable
    • Advanced
    • Ultrasound
  • Ablation Catheters
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Accessory Devices
    • Long Introducer Sheaths
    • Fixed
    • Steerable
    • Transseptal Needles
    • Conventional
    • RF
    • Navigational Accessories

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure Type
    • 1.2.2. Product Coverage
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure Type Segment
    • 2.2.2. Product Coverage Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Electrophysiology Mapping and Ablation Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiac arrhythmias
      • 3.2.1.2. Ongoing technological innovation in EP mapping and ablation
      • 3.2.1.3. Expanding awareness and adoption of AFib screening programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced EP systems and ablation procedures
      • 3.2.2.2. Complex and evolving regulatory compliance requirements
  • 3.3. U.S. Electrophysiology Mapping and Ablation Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Estimates & Trend Analysis

  • 4.1. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Dashboard
  • 4.2. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Movement Analysis
  • 4.3. U.S. Electrophysiology Mapping and Ablation Devices Market Size & Forecasts and Trend Analysis, by Procedure Type, 2021 - 2033 (USD Million)
  • 4.4. EP Ablation Procedures
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By Indication
    • 4.4.3. Atrial Fibrillation
      • 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Paroxysmal AF
        • 4.4.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Persistent AF
        • 4.4.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Long standing persistent/permanent
        • 4.4.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Right Atrial Flutter
      • 4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Left Atrial Flutter
      • 4.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
      • 4.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.7. Right Atrial Tachycardia (AT)
      • 4.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.8. Left Atrial Tachycardia (AT)
      • 4.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.9. Right Wolff-Parkinson-White (WPW)
      • 4.4.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.10. Left Wolff-Parkinson-White (WPW)
      • 4.4.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.11. Right Ventricular Tachycardia (VT)
      • 4.4.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.12. Left Ventricular Tachycardia (VT)
      • 4.4.12.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.13. By Product Type
      • 4.4.13.1. Focal ablation catheter
        • 4.4.13.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.13.1.2. Radiofrequency (RF)
          • 4.4.13.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.13.1.2.2. Conventional
          • 4.4.13.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.13.1.2.3. Irrigated-tip
            • 4.4.13.1.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.4.13.1.2.3.2. Contact-force-sensing
            • 4.4.13.1.2.3.3. Standard
        • 4.4.13.1.3. Alternative energy
          • 4.4.13.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.13.1.4. Pulsed field ablation
          • 4.4.13.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.13.2. Balloon ablation catheters
        • 4.4.13.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Stand-Alone EP Diagnostic Procedures
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Estimates & Trend Analysis

  • 5.1. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Dashboard
  • 5.2. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Movement Analysis
  • 5.3. U.S. Electrophysiology Mapping and Ablation Devices Market Size & Forecasts and Trend Analysis, by Product Coverage, 2021 - 2033 (USD Million)
  • 5.4. Mapping & Lab Systems
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. X-Ray Systems
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Mapping Systems
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. EP Recording Systems
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. ICE Systems
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. RF Ablation Generators
      • 5.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.7. Pulsed Field Ablation Generators
      • 5.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.8. Cryoablation Generators
      • 5.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Diagnostic Catheters
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Conventional
      • 5.5.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.2. Fixed
        • 5.5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.3. Steerable
        • 5.5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Advanced
      • 5.5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Ultrasound
      • 5.5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ablation Catheters
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Focal Ablation Catheter
      • 5.6.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.2. Radiofrequency (RF)
        • 5.6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 5.6.2.2.2. Conventional
          • 5.6.2.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 5.6.2.2.3. Irrigated-tip
          • 5.6.2.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.6.2.2.3.2. Contact-force-sensing
            • 5.6.2.2.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.6.2.2.3.3. Standard
            • 5.6.2.2.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.3. Alternative energy
        • 5.6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.4. Pulsed field ablation
        • 5.6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. Balloon Ablation Catheters
      • 5.6.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Accessory Devices
    • 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Long Introducer Sheaths
      • 5.7.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.2.2. Fixed
        • 5.7.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.2.3. Steerable
        • 5.7.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. Transseptal Needles
      • 5.7.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.3.2. Conventional
        • 5.7.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.3.3. RF
        • 5.7.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.4. Navigational Accessories
      • 5.7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. Siemens Healthineers
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Koninklijke Philips N.V.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Abbott
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Johnson & Johnson (Biosense Webster)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. GE HealthCare
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Boston Scientific Corporation
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Medtronic
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Biotronik SE & Co KG
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. MicroPort Scientific Corporation
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. CardioFocus, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives